Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis.
about
Proteomics in Rheumatoid Arthritis ResearchBottlenecks in the Efficient Use of Advanced Therapy Medicinal Products Based on Mesenchymal Stromal CellsMesenchymal stem cell transplantation in multiple sclerosisUse of mesenchymal stem cells for therapy of cardiac diseaseThe biology and clinical evidence of microfracture in hip preservation surgeryMesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical EvidenceThe defective bone marrow-derived mesenchymal stem cells in patients with chronic immune thrombocytopenia.Mesenchymal stem cells derived from bone marrow of diabetic patients portrait unique markers influenced by the diabetic microenvironment.Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical studyCharacterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis.Alterations in the self-renewal and differentiation ability of bone marrow mesenchymal stem cells in a mouse model of rheumatoid arthritisProteomic analysis of bone marrow-adherent cells in rheumatoid arthritis and osteoarthritis.Mesenchymal stem cells from patients with rheumatoid arthritis display impaired function in inhibiting Th17 cellsMesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates.Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells.Abnormal telomere shortening of peripheral blood mononuclear cells and granulocytes in patients with chronic idiopathic neutropenia.The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.Autophagy regulates odontoblast differentiation by suppressing NF-κB activation in an inflammatory environment.Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia.Mesenchymal stem cells in arthritic diseases.Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patientsTissue engineering in the rheumatic diseasesWhole body tracking of superparamagnetic iron oxide nanoparticle-labelled cells--a rheumatoid arthritis mouse model.Adult stem cells in tissue engineering.Interleukin-17A- or tumor necrosis factor α-mediated increase in proliferation of T cells cocultured with synovium-derived mesenchymal stem cells in rheumatoid arthritis.Smurf control in bone cells.Dermal substitute-assisted healing: enhancing stem cell therapy with novel biomaterial design.Mesenchymal stem cells in the treatment of pediatric diseases.Could mesenchymal stromal cells have a role in childhood autoimmune diseases?Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis.Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis.Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells isolated from experimental autoimmune encephalomyelitis mice.Investigation of Telomerase/Telomeres system in Bone Marrow Mesenchymal Stem Cells derived from IPF and RA-UIPAdipose-derived mesenchymal stem cells from infrapatellar fat pad of patients with rheumatoid arthritis and osteoarthritis have comparable immunomodulatory properties.Bone regeneration in calvarial defects in a rat model by implantation of human bone marrow-derived mesenchymal stromal cell spheroids.Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.Impaired mRNA Expression of the Migration Related Chemokine Receptor CXCR4 in Mesenchymal Stem Cells of COPD Patients.Mesenchymal stem cell therapy in proteoglycan induced arthritis.Inflammatory environment induces gingival tissue-specific mesenchymal stem cells to differentiate towards a pro-fibrotic phenotype.
P2860
Q26786781-6BFF7108-70F8-4015-9090-243DFE8A89C4Q26798278-BB6065E0-5DA0-4F27-8239-6024A7DB0F6EQ26999783-DE1C57CF-BD01-4E78-837E-8E0459C14F95Q27003127-C2116E71-5550-4494-840A-005B42A53B04Q28072782-2B0ADC23-59FE-41D8-B8E3-51CDA22EF678Q28079089-9C5C2FD9-A93D-4620-B390-F5CA01E99B26Q33416398-6A57A4DE-E287-4655-AC75-2874AC56C8CDQ33718101-DC040D58-BBAC-4EA1-A971-CA8F57C6633FQ33767123-BEAA6392-D7CF-4131-93A6-62F59392817BQ34120467-F84773E5-C115-4712-AD82-CDE76687B276Q34153048-F9AC7DED-3D85-4DB3-B31D-483CE061E4B4Q34214030-A5DDD2E0-3AC6-4B4C-86C3-3ADAB87E669CQ35416478-C2D77C30-612B-4C8C-BBFA-0E8EFDEA7D0CQ35757109-774C9A88-BD14-4B91-A3BD-50D5114DC6BFQ35768872-E317A17F-C004-48D6-BC83-4385F5A89E79Q35930629-DA3EFE36-99E3-428C-855D-6AD192F7B353Q36054671-132FD48C-3B50-4CBE-98AE-356497CCE3CCQ36774899-26693ACD-CDB1-4090-9AFE-1981796B53E4Q36776849-5DFD7C9E-8E01-441A-9924-271C56F2A329Q36993256-E31F7BEB-CDBD-46C1-B6F2-CF57264D228DQ37089931-6ED2D220-A935-43EA-BBB8-4117DB74461BQ37207029-F6346434-12AB-43BC-AE6A-AC193BE1DB30Q37372205-8AFCE1DB-EE9D-4ECD-A39B-3D4CBB759A23Q37632398-18BA977D-054C-48D1-B0C6-94CDAC56AAAEQ37690242-0D8D175A-031A-4E88-90ED-80F638835A45Q37761692-54F6C1BA-7728-4169-856A-7BE97C16F951Q37848691-32876B00-7157-464A-89E8-2713460F7157Q38127615-8FAD5377-E9C7-4A83-A7C1-7255C9FA4C7DQ38134131-87281507-98C6-4A95-BAB6-51F8D1CBCFBAQ38818176-F13B768A-AAAA-42C5-9683-8769EF7BB160Q38840236-A4739033-993A-48E2-A783-1035E2CB45A2Q39298145-5594C0D5-C21B-4C2E-B3F6-6AEA086A29E3Q39444572-7B1A74DE-7115-4333-9D43-6D2C311881F3Q39593909-1BEC175D-7D4C-4F6C-A709-5B74CC120559Q40163992-30E84E52-5046-42E3-B506-C90B91B0DA28Q41097319-340E9238-4100-4D74-9DB4-604A6CD96A76Q41196008-90443BE7-1E2A-4D66-A90A-0F98601BD2EBQ41208867-4CE53E16-8F11-4F30-8D8C-29277B8075B7Q42233976-C8BFD5E1-3A9B-443B-B6C3-AD94F0940302Q44228560-08691750-A29D-4D13-8D96-4E2A3B46B019
P2860
Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Functional, molecular and prot ...... cells in rheumatoid arthritis.
@en
Functional, molecular and prot ...... cells in rheumatoid arthritis.
@nl
type
label
Functional, molecular and prot ...... cells in rheumatoid arthritis.
@en
Functional, molecular and prot ...... cells in rheumatoid arthritis.
@nl
prefLabel
Functional, molecular and prot ...... cells in rheumatoid arthritis.
@en
Functional, molecular and prot ...... cells in rheumatoid arthritis.
@nl
P2093
P356
P1476
Functional, molecular and prot ...... cells in rheumatoid arthritis.
@en
P2093
Boumpas DT
Charbord P
Eliopoulos GD
Jorgensen C
Kastrinaki MC
Kritikos H
Papadaki HA
P304
P356
10.1136/ARD.2007.076174
P407
P577
2007-10-05T00:00:00Z